Zdrowie i gospodarka · 20/08/2026

FDA Releases Draft Guidance on Potency Assessment of Active Immunotherapy Products

The US Food and Drug Administration (FDA) has published a draft document outlining recommendations for assessing potency in active immunotherapy products (ACTIMPs), with the goal of improving the quality and efficacy of these treatments.